Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Zagonel

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Rays|January 1, 1997
Treatment of multiple myeloma and acute myelogenous leukemia in the elderly: an updateV Zagonel, R Babare, S Spazzapan, et al.
Cancer Investigation|January 1, 1990
Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphomaV Zagonel, U Tirelli, A Carbone, et al.
Anti-Cancer Drugs|August 1, 1994
Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapyP Tagliaferri, M Caraglia, R Muraro, et al.
American Journal of Clinical Pathology|November 1, 1993
Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineageR Dolcetti, A Carbone, V Zagonel, et al.
Biomed Research International|August 6, 2016
Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the ArtE Bergo, G Lombardi, A Pambuku, et al.
British Journal of Haematology|May 1, 1997
Rarity of microsatellite genomic instability in B-cell non-Hodgkin's lymphomas in hepatitis C virus-infected patientsS De Vita, D Gasparotto, B Pivetta, et al.
Blut|January 1, 1986
Teniposide is not effective in chronic lymphocytic leukemiaV Zagonel, U Tirelli, A Veronesi, et al.
Cancer|June 1, 1986
Non-Hodgkin's lymphoma in the elderly. A retrospective clinicopathologic study of 50 patientsA Carbone, U Tirelli, R Volpe, et al.
Cancer Treatment Reviews|May 1, 1996
Reducing chemotherapy-associated toxicity in elderly cancer patientsV Zagonel, L Fratino, C Sacco, et al.
British Journal of Haematology|August 10, 2000
In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignanciesD Aldinucci, D Poletto, V Zagonel, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Rays|January 1, 1997
Treatment of multiple myeloma and acute myelogenous leukemia in the elderly: an updateV Zagonel, R Babare, S Spazzapan, et al.
Cancer Investigation|January 1, 1990
Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphomaV Zagonel, U Tirelli, A Carbone, et al.
Anti-Cancer Drugs|August 1, 1994
Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapyP Tagliaferri, M Caraglia, R Muraro, et al.
American Journal of Clinical Pathology|November 1, 1993
Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineageR Dolcetti, A Carbone, V Zagonel, et al.
Biomed Research International|August 6, 2016
Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the ArtE Bergo, G Lombardi, A Pambuku, et al.
British Journal of Haematology|May 1, 1997
Rarity of microsatellite genomic instability in B-cell non-Hodgkin's lymphomas in hepatitis C virus-infected patientsS De Vita, D Gasparotto, B Pivetta, et al.
Blut|January 1, 1986
Teniposide is not effective in chronic lymphocytic leukemiaV Zagonel, U Tirelli, A Veronesi, et al.
Cancer|June 1, 1986
Non-Hodgkin's lymphoma in the elderly. A retrospective clinicopathologic study of 50 patientsA Carbone, U Tirelli, R Volpe, et al.
Cancer Treatment Reviews|May 1, 1996
Reducing chemotherapy-associated toxicity in elderly cancer patientsV Zagonel, L Fratino, C Sacco, et al.
British Journal of Haematology|August 10, 2000
In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignanciesD Aldinucci, D Poletto, V Zagonel, et al.
Pageof 16